{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:03:04Z","timestamp":1761948184878,"version":"3.41.0"},"reference-count":29,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"abstract":"\n Background & objectives:<\/jats:title>\n There is paucity of studies on the quality of anticoagulation in neurological patients from India. This study evaluates the quality of oral anticoagulation therapy in neurology patients.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Consecutive patients attending a tertiary care neurology service in north India who were prescribed oral anticoagulant (OAC), were included. Their international normalized ratio (INR) values were prospectively monitored and the earlier INR values of the patients who were already on OAC were retrospectively analyzed. The patients with multi-organ dysfunction, pregnancy and those below 18 yr of age were excluded. The therapeutic INR range was defined as per standard recommendations. The level of anticoagulation, factors interfering with OAC and complications were noted.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The results were based on 77 patients with median age 40 yr. Fifty one patients received OAC for secondary stroke prevention, 23 for cerebral venous sinus thrombosis (CVST) and three for deep vein thrombosis (DVT). A total 167.9 person-years of follow up was done with a median of 1.2 (0.3-9.3) years. Of the 1287 INR reports, 505 (39.3%) reports were in the therapeutic range, 496 (38.5%) were below and 282 (21.91%) were above the therapeutic level. Stable INR was obtained in 33 (42.86%) patients only. INR level was improved by dose adjustment in 20 (26%), drug modification in two (2.6%), and dietary adjustment in six (7.8%) patients. Three patients were sensitive and five were resistant to OAC. Complications were noted in 28 instances; thromboembolic in 16 and haemorrhagic stroke in 12. The overall complication rate was 16.7 per 100 person-years.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n It may be concluded that stable therapeutic INR is difficult to maintain in neurological patients. Optimal modification of diet, drug and dose of oral anticoagulant may help in stabilization of INR.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0971-5916.184301","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T17:35:08Z","timestamp":1466703308000},"page":"428-433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Quality of anticoagulation therapy in neurological patients in a tertiary care hospital in north India"],"prefix":"10.25259","volume":"143","author":[{"given":"Prabhat","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-9-20241212","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"49","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-9-20241212","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1468-1331.2010.03011.x","article-title":"EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients","volume":"17","author":"Einh\u00e4upl","year":"2010","journal-title":"Eur J Neurol"},{"key":"R3-9-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"R4-9-20241212","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1468-1331.2010.03011.x","article-title":"European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients","volume":"17","author":"Einh\u00e4upl","year":"2010","journal-title":"Eur J Neurol"},{"key":"R5-9-20241212","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Antithrombotic therapy and prevention of thrombosis panel, 9th ed. Evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"R6-9-20241212","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: Evidence-based clinical practice guidelines, 8th ed","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"R7-9-20241212","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R8-9-20241212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-12-14","article-title":"Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression","volume":"12","author":"Mearns","year":"2014","journal-title":"Thromb J"},{"key":"R9-9-20241212","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"R10-9-20241212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1755-7682-3-8","article-title":"Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes","volume":"3","author":"Benavente","year":"2010","journal-title":"Int Arch Med"},{"key":"R11-9-20241212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12055-011-0109-1","article-title":"Pattern of oral anticoagulant use following prosthetic heart Valve replacement","volume":"27","author":"Dhanya","year":"2011","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"R12-9-20241212","first-page":"847","article-title":"Outpatient oral anticoagulant management: audit of 82 patients","volume":"53","author":"Kakkar","year":"2005","journal-title":"J Assoc Phyicians India"},{"key":"R13-9-20241212","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.2011.08753.x","article-title":"Guidelines on oral anticoagulation with warfarin - fourth edition","volume":"154","author":"Keeling","year":"2011","journal-title":"Br J Haematol"},{"key":"R14-9-20241212","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"key":"R15-9-20241212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-006-9022-7","article-title":"The international study of anticoagulation management (ISAM)","volume":"23","author":"Ansell","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"R16-9-20241212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(94)92620-4","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke Prevention in Atrial Fibrillation II Study","volume":"343","author":"Ezekowitz","year":"1994","journal-title":"Lancet"},{"key":"R17-9-20241212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N Engl J Med"},{"key":"R18-9-20241212","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Study on complications of oral anticoagulant therapy (ISCOAT)","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"R19-9-20241212","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1013228718768","article-title":"Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease","volume":"1","author":"Horstkotte","year":"1998","journal-title":"J Thromb Thrombolysis"},{"key":"R20-9-20241212","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.281.2.145","article-title":"A structured teaching and self-management program for patients receiving oral anticoagulation","volume":"281","author":"Sawicki","year":"1999","journal-title":"JAMA"},{"key":"R21-9-20241212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0038-1648869","article-title":"Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients","volume":"72","author":"Azar","year":"1994","journal-title":"Thromb Haemost"},{"key":"R22-9-20241212","first-page":"188","article-title":"A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol)","volume":"71","author":"Pattacini","year":"1994","journal-title":"Thromb Haemost"},{"key":"R23-9-20241212","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2009-02-207928","article-title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy (WARPED)","volume":"114","author":"Witt","year":"2009","journal-title":"Blood"},{"key":"R24-9-20241212","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1538-7836.2010.03756.x","article-title":"Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users","volume":"8","author":"Witt","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R25-9-20241212","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"R26-9-20241212","first-page":"335","article-title":"Improvement of oral anticoagulation therapy by INR self-management","volume":"13","author":"Horstkotte","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"R27-9-20241212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-133-9-200011070-00010","article-title":"A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial","volume":"133","author":"Beyth","year":"2000","journal-title":"Ann Intern Med"},{"key":"R28-9-20241212","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of INR control achieved by centres and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"R29-9-20241212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jcp.49.1.5","article-title":"Audit of anticoagulant therapy","volume":"49","author":"Rose","year":"1996","journal-title":"J Clin Pathol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201643040-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:57:28Z","timestamp":1751497048000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/quality-of-anticoagulation-therapy-in-neurological-patients-in-a-tertiary-care-hospital-in-north-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.184301","relation":{},"ISSN":["0971-5916"],"issn-type":[{"type":"print","value":"0971-5916"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}